Events2Join

CONCURRENT CHEMORADIOTHERAPY IN THE MANAGEMENT ...


Concurrent chemoradiotherapy in the management of advanced...

Data of eight randomized trials published in the English literature demonstrated the superiority of concurrent cisplatin plus RT over RT alone in terms of ...

Mature results of a Phase III randomized trial comparing concurrent ...

This Phase III randomized trial compared radiation therapy with radiation and concurrent chemotherapy with cisplatin and 5-fluorouracil in ...

Concurrent chemoradiotherapy in the management of advanced ...

These trials can be classified according to the timing of the chemotherapy, which was given either concurrently with RT (in three trials) or concurrently with ...

Concurrent Chemoradiotherapy - SpringerLink

Initial efforts to integrate systemic chemotherapy into the definitive management of squamous cell head and neck cancer focused on sequential treatment ...

Improving the efficacy and safety of concurrent chemoradiotherapy ...

Therefore, new treatment modalities for LACC need to be explored. A preliminary study demonstrated that neoadjuvant chemotherapy (NACT) combined ...

Concurrent Chemoradiotherapy Followed by Adjuvant Cisplatin ...

The authors explained in the background that patients with N2-3 nasopharyngeal carcinoma have a high risk of treatment being unsuccessful ...

Neoadjuvant versus concurrent chemotherapy in the management ...

The 2-year failure free survival in the concurrent chemoradiation arm was 63% versus 35% in the neoadjuvant arm (p = 0.197). Survival analyses ...

Induction sintilimab and chemotherapy followed by concurrent ...

Concurrent chemoradiotherapy is the standard nonoperative treatment for locally advanced esophageal squamous cell carcinoma. However, local ...

Treatment outcomes of a prospective, multicentric clinical study

IMRT with concurrent cisplatin chemotherapy resulted in encouraging rates of local and distant control and overall survival with acceptable rates of acute and ...

Concurrent Chemoradiotherapy for Unresectable Stage III Non ...

These include induction chemotherapy and concurrent chemoradiotherapy. Both approaches have been shown to be superior to radiation therapy alone ...

Concurrent Chemoradiation Strategies in the Management of ...

Furthermore, recent studies in good performance status, stage III patients have shown that concurrent chemoradiotherapy improves survival compared to sequential ...

The role of chemoradiotherapy and immunotherapy in stage III NSCLC

For unresectable stage III NSCLC, definitive concurrent chemoradiotherapy (CCRT) was historically recommended as a treatment with a 5-year ...

The efficacy and safety of concurrent chemoradiotherapy with ...

Concurrent chemoradiotherapy (CCRT) can significantly improve the survival rate of patients and has become the standard treatment mode for advanced NPC (4).

Concurrent systemic therapy with radiotherapy for the treatment of ...

Only two phase III studies specifically including poor-risk patients have been published. Some recent studies suggested that tolerable radio-sensitizing therapy ...

Radiation therapy, chemoradiotherapy, neoadjuvant approaches ...

Outline ; Preoperative chemoradiotherapy · Concurrent chemoradiotherapy · Sequential chemoradiotherapy ; Necessity for surgery · Chemoradiotherapy ...

Analysis of Treatment Outcomes and Prognosis After Concurrent ...

The aims of this study were to investigate the short-term and long-term efficacies and chronic radiotoxicity of concurrent chemoradiotherapy (CCRT) combined ...

Concurrent chemo-radiation in the conservative management of ...

Purpose: Sequencing of chemotherapy (CTX) with radiation (RT) in the conservative management of breast cancer (CS+RT) remains controversial.

Concurrent chemoradiotherapy versus radiotherapy alone for ...

Conclusion: Compared with IMRT alone, CCRT provided survival benefit with acceptable toxicity in patients with LANPC. However, we need ...

an open-label, phase 3, randomised, superiority trial - The Lancet

Concurrent chemoradiotherapy is the standard of care in limited-stage small-cell lung cancer, but the optimal radiotherapy schedule and dose ...

Concurrent chemoradiotherapy in older adults with squamous cell ...

Objective: Treatment for head and neck cancers incurs substantial associated morbidities, which can be of potentially greater significance ...